{{Rsnum
|rsid=742134
|Gene=BIK
|Chromosome=22
|position=43122269
|Orientation=plus
|GMAF=0.1217
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BIK
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 22.1 | 77.0
| HCB | 0.7 | 10.9 | 88.3
| JPT | 0.0 | 12.4 | 87.6
| YRI | 2.0 | 28.6 | 69.4
| ASW | 0.0 | 24.6 | 75.4
| CHB | 0.7 | 10.9 | 88.3
| CHD | 0.0 | 8.3 | 91.7
| GIH | 2.0 | 24.8 | 73.3
| LWK | 2.7 | 32.7 | 64.5
| MEX | 5.2 | 17.2 | 77.6
| MKK | 3.8 | 17.3 | 78.8
| TSI | 1.0 | 19.6 | 79.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=G
|Pval=0.000006
|OR=1.1600
|ORtxt=[1.01-1.23]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}